QTRX Net Margin
-80.29%TTM
Period ending:
QTRX FY Net Margin%
-10.40%-144.78%
2015-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
QTRX net margin history
Net income as a percentage of revenue. The available annual fiscal periods series contains 11 observations from Dec 31, 2015 to Dec 31, 2025.
| Period ending | Net Margin |
|---|---|
| -77.2787% | |
| -28.4496% | |
| -23.4062% | |
| -94.3633% | |
| -50.2442% | |
| -36.5028% | |
| -71.9075% | |
| -82.4963% | |
| -118.121% | |
| -131.7771% | |
| -130.8949% |
Compare net margin
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) net margin
- Bridgebio Pharma Inc (BBIO) net margin
- Brightspring Health Services Inc (BTSG) net margin
- Madrigal Pharmaceuticals Inc (MDGL) net margin
- Ensign Group Inc (ENSG) net margin
- Glaukos Corp (GKOS) net margin
- Krystal Biotech Inc (KRYS) net margin
- Twist Bioscience Corp (TWST) net margin
Compare all covered stocks by net margin →
All QTRX financial metrics · QTRX stock overview · How to interpret financial metrics
